LGALS9

Galectin-9 · O00182 · LGALS9 on Sugi Atlas →

15,003 patent compounds predicted against LGALS9, 8,695 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL3278668 SCHEMBL3278668 0.54 10/20
SCHEMBL3284428 SCHEMBL3284428 0.54 10/20
SCHEMBL3284431 SCHEMBL3284431 0.51 10/20
SCHEMBL2430521 SCHEMBL2430521 1.00 9/20
SCHEMBL2430523 SCHEMBL2430523 1.00 9/20
SCHEMBL3276516 SCHEMBL3276516 0.54 9/20
SCHEMBL1425152 SCHEMBL1425152 1.00 8/20
SCHEMBL2432165 SCHEMBL2432165 1.00 8/20
SCHEMBL2432167 SCHEMBL2432167 1.00 8/20
SCHEMBL3277373 SCHEMBL3277373 1.00 8/20
SCHEMBL3278173 SCHEMBL3278173 0.86 8/20
SCHEMBL3276985 SCHEMBL3276985 0.86 8/20
SCHEMBL2432200 SCHEMBL2432200 0.74 8/20
SCHEMBL2432203 SCHEMBL2432203 0.74 8/20
SCHEMBL2432865 SCHEMBL2432865 0.69 8/20
SCHEMBL2432867 SCHEMBL2432867 0.69 8/20
SCHEMBL2431042 SCHEMBL2431042 0.66 8/20
SCHEMBL2431045 SCHEMBL2431045 0.66 8/20
SCHEMBL3278577 SCHEMBL3278577 0.66 8/20
SCHEMBL2429950 SCHEMBL2429950 0.64 8/20

Clinical trials — most relevant to LGALS9 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer PHASE3RECRUITING
A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease PHASE2COMPLETED
A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes PHASE2UNKNOWN
A Phase 2 Extension Study of Study GCS-100-CS-4002 PHASE2COMPLETED
Vitamin D Deficiency Treatment Outcomes After Non-ST-Segment Elevation Myocardial Infarction PHASE2UNKNOWN
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer PHASE2RECRUITING
Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSA PHASE2COMPLETED
GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients PHASE1COMPLETED
Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ Damage nanUNKNOWN
The Diagnostic Value of Serum Oncostatin M and Galactin 3 as Biomarkers in Diagnosis of Ulcerative Colitis Disease nanNOT_YET_RECRUITING
The Role of Galectins in the Non-invasive Diagnosis of Endometriosis nanUNKNOWN
A Serum Galectin-3 Levels in Placenta Accreta Spectrum Pregnancies nanCOMPLETED
Urinary G3BP as a Novel Biomarker in Lupus Nephritis nanNOT_YET_RECRUITING
Galectin-3 Binding Protein in Cardiovascular Disease and Chronic Heart Failure nanCOMPLETED
An Exosomal miRNA-based Liquid Biopsy for ICC Detection nanCOMPLETED
Galectin and Respiratory Weaning nanUNKNOWN
Galectin-3 in Septic and Non-septic Acute Kidney Injury nanUNKNOWN
Galectin-3 for Thromboembolic Formation in Patients With Atrial Fibrillation CHA₂DS₂-VASc Scoring nanUNKNOWN
Effect of Low-Glycemic Index Mediterranean Diet on AGEs nanCOMPLETED
Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer nanNOT_YET_RECRUITING
Galectin 3 Dosage in Diagnosis of Nodular and Multinodular Goiter nanCOMPLETED
Association of CD49d and CD44 in CLL Patients and Their Role in Prognosis nanUNKNOWN
Testicular Proteins for Sperm Retrieval Prediction Protein1, Testis-Expressed Gene 101, and Lectin Galactoside-binding Protein in Predicting Surgical Sperm Retrieval in Men With Non-Obstructive Azoospermia nanUNKNOWN
Evaluation of Galectin-3 in Serum and Saliva of Pemphigus Patients nanUNKNOWN
Biomarkers for Risk Stratification After STEMI nanUNKNOWN
PDAC Peripheral and Portal Vein Sampling nanCOMPLETED
Forecasting Occult liveR Metastasis Using an Exosomal Signature for Intelligent Guided Hepatic Targeting nanCOMPLETED
Galectin-3 in Patients With Endometriosis nanUNKNOWN
Galectin-3 as a Biomarker in Patients With Chagas Disease nanCOMPLETED
KIDney Injury in Times of COVID-19 (KIDCOV) nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a LGALS9 binder may also engage these)

ProteinNameSimilarity
Q6DKI2 1.000 Q6DKI2 →
Q3B8N2 1.000 Q3B8N2 →
Q3MHZ8 0.995 Q3MHZ8 →
P97840 0.993 P97840 →
O08573 0.990 O08573 →
LGALS4 Galectin-4 0.978 landscape →
Q29058 0.978 Q29058 →
O54891 0.977 O54891 →
P47967 0.975 P47967 →
Q3T0D6 0.971 Q3T0D6 →
Q8K419 0.971 Q8K419 →
P38552 0.971 P38552 →
LGALS8 Galectin-8 0.959 landscape →
P07583 0.957 P07583 →
Q62665 0.955 Q62665 →
Q5R7M1 0.955 Q5R7M1 →
Q9JL15 0.955 Q9JL15 →
C0HJQ1 0.954 C0HJQ1 →
LGALS3 Galectin-3 0.954 landscape →
P97590 0.953 P97590 →
P81184 0.952 P81184 →
C0HJR3 0.951 C0HJR3 →
P47953 0.951 P47953 →
P47845 0.949 P47845 →
P11762 0.949 P11762 →
P48538 0.948 P48538 →
Q9Z144 0.947 Q9Z144 →
P16110 0.946 P16110 →
P11116 0.946 P11116 →
Q49I35 0.946 Q49I35 →